Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saskia Janssen

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
British Journal of Clinical Pharmacology|January 9, 2020
Early antituberculosis drug exposure in hospitalized patients with human immunodeficiency virus-associated tuberculosisCharlotte Schutz, Maxwell Chirehwa, David Barr, et al.
Wellcome Open Research|March 4, 2024
Pharmacokinetics of antitubercular drugs in patients hospitalized with HIV-associated tuberculosis: a population modeling analysisNoha Abdelgawad, Maxwell Chirehwa, Charlotte Schutz, et al.
Tropical Medicine & International Health : TM & IH|June 13, 2012
Dengue in travellers: applicability of the 1975-1997 and the 2009 WHO classification system of dengue feverRosanne W Wieten, Wytze Vlietstra, Abraham Goorhuis, et al.
Plos Medicine|July 6, 2019
Clinical, microbiologic, and immunologic determinants of mortality in hospitalized patients with HIV-associated tuberculosis: A prospective cohort studyCharlotte Schutz, David Barr, Bruno B Andrade, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2017
Mortality in Severe Human Immunodeficiency Virus-Tuberculosis Associates With Innate Immune Activation and Dysfunction of MonocytesSaskia Janssen, Charlotte Schutz, Amy Ward, et al.
Clinical Pharmacokinetics|October 11, 2025
Bridging to Paediatric Dosing: Relative Bioavailability of Suspended Rifapentine and Isoniazid in an Open-Label Randomized Trial in Adults on Tuberculosis Preventive TherapySaskia Janssen, Thanakorn Vongjarudech, Mats O Karlsson, et al.
The Journal of Infectious Diseases|April 1, 2017
Hemostatic Changes Associated With Increased Mortality Rates in Hospitalized Patients With HIV-Associated Tuberculosis: A Prospective Cohort StudySaskia Janssen, Charlotte Schutz, Amy M Ward, et al.
BMJ Open|September 10, 2018
Effectiveness of service models and organisational structures supporting tuberculosis identification and management in hard-to-reach populations in countries of low and medium tuberculosis incidence: a systematic reviewCharlotte C Heuvelings, Patrick F Greve, Sophia G de Vries, et al.
The Lancet. Infectious Diseases|March 15, 2017
Effectiveness of interventions for diagnosis and treatment of tuberculosis in hard-to-reach populations in countries of low and medium tuberculosis incidence: a systematic reviewCharlotte C Heuvelings, Sophia G de Vries, Patrick F Greve, et al.
The Lancet. Infectious Diseases|March 15, 2017
Barriers and facilitators to the uptake of tuberculosis diagnostic and treatment services by hard-to-reach populations in countries of low and medium tuberculosis incidence: a systematic review of qualitative literatureSophia G de Vries, Anne L Cremers, Charlotte C Heuvelings, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
British Journal of Clinical Pharmacology|January 9, 2020
Early antituberculosis drug exposure in hospitalized patients with human immunodeficiency virus-associated tuberculosisCharlotte Schutz, Maxwell Chirehwa, David Barr, et al.
Wellcome Open Research|March 4, 2024
Pharmacokinetics of antitubercular drugs in patients hospitalized with HIV-associated tuberculosis: a population modeling analysisNoha Abdelgawad, Maxwell Chirehwa, Charlotte Schutz, et al.
Tropical Medicine & International Health : TM & IH|June 13, 2012
Dengue in travellers: applicability of the 1975-1997 and the 2009 WHO classification system of dengue feverRosanne W Wieten, Wytze Vlietstra, Abraham Goorhuis, et al.
Plos Medicine|July 6, 2019
Clinical, microbiologic, and immunologic determinants of mortality in hospitalized patients with HIV-associated tuberculosis: A prospective cohort studyCharlotte Schutz, David Barr, Bruno B Andrade, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2017
Mortality in Severe Human Immunodeficiency Virus-Tuberculosis Associates With Innate Immune Activation and Dysfunction of MonocytesSaskia Janssen, Charlotte Schutz, Amy Ward, et al.
Clinical Pharmacokinetics|October 11, 2025
Bridging to Paediatric Dosing: Relative Bioavailability of Suspended Rifapentine and Isoniazid in an Open-Label Randomized Trial in Adults on Tuberculosis Preventive TherapySaskia Janssen, Thanakorn Vongjarudech, Mats O Karlsson, et al.
The Journal of Infectious Diseases|April 1, 2017
Hemostatic Changes Associated With Increased Mortality Rates in Hospitalized Patients With HIV-Associated Tuberculosis: A Prospective Cohort StudySaskia Janssen, Charlotte Schutz, Amy M Ward, et al.
BMJ Open|September 10, 2018
Effectiveness of service models and organisational structures supporting tuberculosis identification and management in hard-to-reach populations in countries of low and medium tuberculosis incidence: a systematic reviewCharlotte C Heuvelings, Patrick F Greve, Sophia G de Vries, et al.
The Lancet. Infectious Diseases|March 15, 2017
Effectiveness of interventions for diagnosis and treatment of tuberculosis in hard-to-reach populations in countries of low and medium tuberculosis incidence: a systematic reviewCharlotte C Heuvelings, Sophia G de Vries, Patrick F Greve, et al.
The Lancet. Infectious Diseases|March 15, 2017
Barriers and facilitators to the uptake of tuberculosis diagnostic and treatment services by hard-to-reach populations in countries of low and medium tuberculosis incidence: a systematic review of qualitative literatureSophia G de Vries, Anne L Cremers, Charlotte C Heuvelings, et al.
Pageof 4